Federal Circuit strikes down Apotex patent for inequitable conduct

18-08-2014

The US Court of Appeals for the Federal Circuit has affirmed a lower court’s ruling that an Apotex patent covering a method of making a drug is unenforceable due to inequitable conduct by the company’s founder and chairman Bernard Sherman.


US Court of Appeals for the Federal Circuit, Apotex, UCB, Univasc, Bernard Sherman

LSIPR